Navigation Links
Cardica Announces Fiscal 2008 Second Quarter Financial Results and Business Progress
Date:1/24/2008

g that C-Port xA(R) and C-Port(R) Flex-A(R) Distal

Anastomosis Systems produce excellent patency in off-pump cardiac

bypass surgery;

-- Hosted a premier live webcast demonstrating the use of the C-Port xA

and the C-Port Flex-A systems during an off-pump coronary artery bypass

graft (CABG) procedure and a taped robotic closed-chest bypass surgery,

respectively; and

-- Launched C-Port xA X-CHANGE system, a cartridge-based system, and will

feature it at the Annual Meeting of the Society of Thoracic Surgeons

which is taking place Jan. 25-30 in Fort Lauderdale, Fla.

Corporate

-- Raised $15.4 million in net proceeds through the sale of 1,981,170

shares of Cardica's common stock; and

-- Received $2 million from Cook Medical for multiple milestones under the

Cook Vascular Closure Device and patent foramen ovale (PFO) license,

development and commercialization agreements.

Fiscal 2008 Second Quarter and Six Months Ended December 31, 2007 Financial Results

Total revenue was approximately $1.7 million for the fiscal 2008 second quarter compared to approximately $0.9 million for the fiscal 2007 second quarter. Total product revenue was approximately $1.3 million for the fiscal 2008 second quarter compared to approximately $0.4 million for the same period in fiscal 2007. Cost of product revenue was approximately $1.2 million for the fiscal 2008 second quarter compared to approximately $0.9 million for the fiscal 2007 second quarter.

Research and development expenses were approximately $1.7 million for both the fiscal 2008 and 2007 second quarters. Selling, general and administrative expenses for the fiscal 2008 second quarter were approximately $3.2 million compared to approximately $2.2 million for the same period in fiscal 2007.

The net loss for the fiscal 2008 second quarter was approximately $4.2 million, or $0.29 per share, com
'/>"/>

SOURCE Cardica, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Cardica and Intuitive Surgical to Host Educational Symposium on Advanced Techniques and Technologies in Robotic Coronary Revascularization and Mitral Valve Repair
2. Cardica and Cook Sign Agreement to Expand Cook Vascular Closure Device Product Family
3. Cardica Receives European CE Mark for C-Port Flex A System for Use in Coronary Artery Bypass Surgery
4. Cardicas C-Port(R) Flex A Anastomosis System Allows Surgeons to Perform Revolutionary Closed-Chest Heart Bypass Surgeries
5. Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year End 2007 Financial Results
6. Gerson Lehrman Group Announces Partnership With BIO to Provide Scientific Expertise for the BIO CEO & Investor Conference
7. Accuray Announces New Treatment Planning Service Offering
8. QED International Associates Announces Changes to the HealthShares(TM) Composite, HealthShares(TM) Cancer and HealthShares(TM) Neuroscience Indexes
9. Sharps Compliance Corp. Announces Purchase of Medical Waste Disposal Facility and Addition of Autoclave Technology
10. ProMetic announces scale-up of prion removal resin in plasma product for biopharmaceutical use
11. Vapotherm(R) Announces Validation of U.S. Patent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... 4, 2015 Lancée ... Paris en décembre 2011, l,étude collaborative ... », qui compare   l es microsphères ... sorafénib dans le carcinome hépatocellulaire avancé, a recruté ... foie avancé   ; les résultats sont attendus ...
(Date:3/3/2015)... - Aptose Biosciences Inc. (NASDAQ: APTO, TSX: APS), a ... target the underlying mechanisms of cancer, today reported financial ... 31, 2014. Effective July 17, 2014, the ... to December 31. As a result of that change, ... quarter and the seven months ended December 31, 2014, ...
(Date:3/3/2015)... astronaut Scott Kelly , who is making final preparations ... and working on the International Space Station, will be available ... Monday, March 9. Kelly will participate from ... of his training. The interviews will be preceded at 5 ... training and previous spaceflights. To schedule an interview, ...
(Date:3/3/2015)... - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced ... control projects in North America , the ... "Bidding activity in 2015 continues to be robust" said ... volume year for bidding in 2014, we are pleased to see ... reflect the organization,s renewed focus on select market segments where we ...
Breaking Biology Technology:Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 2Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 3Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 4Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 5Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 6Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 2Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 3Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 4Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 5Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 6Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 7Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 8Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 9Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 10Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 11Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 12NASA Astronaut Scott Kelly Available for Interviews before One-Year Space Station Mission 2
... Sigma-Aldrich Corporation (Nasdaq: SIAL ) will be presenting at the Baird,s 2010 ... CDT ( 2:15 PM EDT ) in Chicago, IL.  Interested ... http://investor.sigmaaldrich.com/ .  Users can click the "Webcast" icon to access this file.   ... About Sigma-Aldrich: ...
... May 17 Three years of teamwork between Elekta ... University Heavy Ion Medical Center used carbon ion radiotherapy to treat a ... use of Elekta,s treatment planning software, XiO® , for delivery with ... , , ...
... May 17 Eli Lilly and Company will unveil data ... of Clinical Oncology (ASCO) in Chicago, Ill. from June ... latest research results on ALIMTA® (pemetrexed for injection) and GEMZAR® (gemcitabine HCl ... Merck-Serono.   , , , ...
Cached Biology Technology:Sigma-Aldrich Corporation to Present at the Baird's 2010 Growth Stock Conference on Thursday, May 20, 2010 2Elekta / Mitsubishi Electric Collaboration Helps Japan's Gunma University Heavy Ion Medical Center Launch Advanced Carbon Ion Therapy for Treating Cancer 2Lilly Oncology to Unveil More Than 50 Studies at ASCO 2010 2Lilly Oncology to Unveil More Than 50 Studies at ASCO 2010 3Lilly Oncology to Unveil More Than 50 Studies at ASCO 2010 4Lilly Oncology to Unveil More Than 50 Studies at ASCO 2010 5Lilly Oncology to Unveil More Than 50 Studies at ASCO 2010 6Lilly Oncology to Unveil More Than 50 Studies at ASCO 2010 7Lilly Oncology to Unveil More Than 50 Studies at ASCO 2010 8Lilly Oncology to Unveil More Than 50 Studies at ASCO 2010 9Lilly Oncology to Unveil More Than 50 Studies at ASCO 2010 10Lilly Oncology to Unveil More Than 50 Studies at ASCO 2010 11Lilly Oncology to Unveil More Than 50 Studies at ASCO 2010 12Lilly Oncology to Unveil More Than 50 Studies at ASCO 2010 13
(Date:2/5/2015)... 26, 2015   Epic Sciences , a precision diagnostics ... that Murali Prahalad , Ph.D., president and CEO, is ... (PMWC) 2015: Silicon Valley, which is taking place at ... on January 26-28, 2015. Dr. ... as Biomarkers." Last year, Epic Sciences was a finalist in ...
(Date:2/5/2015)... , Jan. 28, 2015 NXT-ID, Inc. ... the "Company"), a biometric authentication company focused on the ... the upcoming RedChip Global Online CEO Conference on January ... Gino Pereira , CEO of NXT-ID will ... lead product, the Wocket smart wallet and its full ...
(Date:1/22/2015)... , Jan. 22, 2015 Research and Markets ... "Biometrics - A Global Market Overview" report to their ... technology is to ensure that an individual is who she/he ... may make use of a person,s unique physical characteristics, such ...
Breaking Biology News(10 mins):Epic Sciences to Present at Personalized Medicine World Conference 2015 on the Use of Circulating Tumor Cells as Cancer Biomarkers 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3Biometrics - A Global Market Overview 2Biometrics - A Global Market Overview 3
... As nations from around the world meet in Copenhagen from ... Change, researchers from the University of Delaware are taking a ... on Oceans, Coasts, and Islands, housed at UD, is being ... world,s oceans. Oceans Day, to be held Dec. ...
... they pop the champagne corks to celebrate New Year,s Eve, ... behind them. That,s because pharmaceutical companies who make top-selling drugs ... tough year in the midst of mounting market pressures and ... of the pharmaceutical industry is scheduled for the current issue ...
... published this week in the journal Proceedings of the ... structure and function of a key player in regulating chromatin ... assistant professor of medical genetics and a scientist at The ... Family Research Institute. Chromatin, a dynamic DNA-protein complex, is ...
Cached Biology News:Oceans day at International Climate Change Conference 2
Spaced cover glasses to promote effective hybridization...
Disposable tips with floating filter (US Patent 6,702,990) for PDM1.5 OneTouch Plus spotpicker, 10 racks of 96, DNAse and RNAse free...
... Detection Platform combines robust chemistry with ... sensitive, specific, and cost-effective detection method ... Platform offers exceptional performance with specificity ... high signal/background ratio, and an expanded ...
...
Biology Products: